immune system
|
• macrophage uptake and degradation of acetylated low density lipoproteins involved in the development of atherosclerosis
|
|
hm1
|
Msr1tm1Csk/Msr1tm1Csk
involves: 129S7/SvEvBrd * C57BL/6J |
|
|||||||||||||||||
|
• macrophage uptake and degradation of acetylated low density lipoproteins involved in the development of atherosclerosis
|
|
hm2
|
Msr1tm1Csk/Msr1tm1Csk
involves: 129X1/SvJ * ICR |
|
|||||||||||||||||
|
• decreased survival after infection with Listeria monocytogenes
|
|
• decreased survival after infection with herpes simplex virus, HSV-1
|
|
• mutants produce higher levels of Il-12 in vivo in response to CpG oligodeoxynucleotide administration compared to wild-type mice
|
|
• decreased survival after infection with Listeria monocytogenes
|
|
• decreased survival after infection with herpes simplex virus, HSV-1
|
|
cx3
|
Apoetm1Unc/Apoetm1Unc Msr1tm1Csk/Msr1tm1Csk either: (involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J * ICR) or (involves: 129P2/OlaHsd * 129X1/SvJ * 129/Sv * ICR) |
|
|||||||||||||||||
|
• atherosclerotic plaques, but smaller than those seen in Apoetm1Unc mutant mice
|
|
• increased plasma cholesterol concentrations
• plasma cholesterol concentrations greater than Apoetm1Unc mutant mice
|
|
cx4
|
Msr1tm1Csk/Msr1tm1Csk Scarf1tm1Ishi/Scarf1tm1Ishi involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J |
|
|||||||||||||||||
|
• macrophage uptake and degradation of acetylated low density lipoproteins involved in the development of atherosclerosis
• this reduction is slightly greater than that of Msr1tm1Kod homozygotes
|
|
cx5
|
Marcotm1Ktry/Marcotm1Ktry Msr1tm1Csk/Msr1tm1Csk involves: 129X1/SvJ * C57BL/6 |
|
|||||||||||||||||
|
• microarchitecture of the spleen marginal zone is altered
• marginal zones have fewer numbers of SIGNR1+ cells that do not tightly adhere to each other resulting in a gap between the marginal zone and the sinus that is more severe than in Marcotm1Ktry homozygotes
|
|
• anti-polysaccharide IgM levels are increased
|
|
• macrophage adhesion or spreading is absent
|
|
• following immunization and infection with pneumoccocal bacterial serotype, mice have a decreased anti-polysaccharide IgM response
• following immunization and infection with pneumoccocal bacterial serotype, IgG3 response is virtually non-existent
|
|
• microarchitecture of the spleen marginal zone is altered
• marginal zones have fewer numbers of SIGNR1+ cells that do not tightly adhere to each other resulting in a gap between the marginal zone and the sinus that is more severe than in Marcotm1Ktry homozygotes
|
|
cx6
|
Msr1tm1Csk/Msr1tm1Csk Tg(APPV717F)109Ili/? involves: 129X1/SvJ * C57BL/6 * DBA/2 * ICR |
|
|||||||||||||||||
|
• loss of synaptophysin-immunoreactive presynaptic terminals in the hippocampal outer molecular layer (loss was similar to that seen in wild-type (Msr1+) mice heterozygous for Tg(APP)109Ili )
• reduced density of MAP-2 immuoreactive neuronal dendrites in the outer molecular layer of the hippocampus (loss was similar to that seen in wild-type (Msr1+) mice heterozygous for Tg(APP)109Ili)
|
|
• number and distribution of plaques was similar to those seen in wild-type (Msr1+) mice heterozygous for Tg(APP)109Ili
|
|
• number and distribution of plaques was similar to those seen in wild-type (Msr1+) mice heterozygous for Tg(APP)109Ili
|
Mouse Models of Human Disease |
OMIM ID | Ref(s) | |
| Alzheimer Disease; AD | 104300 | J:58338 | |